Results. Multimicronutrient interventions for groups with higher needs may include home fortification products for young children or supplements for pregnant and lactating women. The choice of preparation should be guided by target group needs, evidence of efficacy of a product or its compounds, acceptability, and costeffectiveness. Different designs can be used to assess whether an intervention has the desired impact. First, program implementation and adherence must be ascertained. Then, impact on micronutrient status can be assessed, but design options are often limited by logistic challenges, available budget, security issues, and ethical and practical issues regarding nonintervention or placebo groups. Under these conditions, a plausibility design using pre-and postintervention cross-sectional surveys, a prospective cohort study, or a step-wedge design, which enrolls groups as they start receiving the intervention, should be considered. Post hoc comparison of groups with different adherence levels may also be useful. Hemoglobin is often selected as an impact indicator because it is easily measured and tends to respond to change in micronutrient status, especially iron. However, it is not a very specific indicator of micronutrient status, because it is also influenced by inflammation, parasitic infestation, physiological status (age, pregnancy), altitude, and disorders such as thalassemia and sickle cell disease.
cies have long been recognized as a public health problem in many populations, particularly among high-risk groups such as young children, pregnant and lactating women, and adolescent girls. In the past, individual micronutrient deficiencies tended to be tackled separately through the use of specific supplements, such as iron and folic acid tablets for pregnant women, highdose vitamin A capsules for young children, and salt iodization for the general population. Since the late 1990s, however, the focus of prevention and treatment of micronutrient deficiencies has shifted to multiple micronutrient supplementation, for two main reasons. First, the most common cause of micronutrient deficiencies is inadequate dietary intake of micronutrients. Because foods contain combinations of nutrients, low vitamin A intake, for example, indicates that the intakes of several other micronutrients are probably low as well. Second, advanced analytical techniques and their application to biomarkers of nutrient status have confirmed that deficiencies are not limited to the most well-known micronutrients, such as iron, vitamin A, iodine, and zinc, but also include others, such as selenium, folate, and vitamins B 6 and B 12 .
Different interventions are being used to prevent and treat micronutrient deficiencies at the population level. These include supplementation; home fortification; fortification of special food products, common staples, and condiments; and improvements in dietary diversity through approaches that include homestead food production and nutrition education. As these approaches are being increasingly scaled up, it is important to monitor and evaluate their implementation and impact in order to know whether the interventions are having the desired effect and, if they are not, to identify likely causes and potential solutions.
In March 2009, representatives of the World Food Programme and the United Nations High Commissioner for Refugees organized a one-day meeting of experts to discuss the evaluation of programs aimed at reducing multiple micronutrient deficiencies, particularly in emergency and refugee settings. Topics discussed included the selection of impact indicators (especially biomarkers of nutrient status), factors that must be taken into account when hemoglobin concentration is used as an impact indicator, target groups for the intervention and the evaluation, assessment of adherence to the intervention, design of the impact evaluation, and data collection. This paper reports the discussions of that meeting.
Type of programs to be evaluated
The meeting discussions focused on programs that provide specific micronutrient-rich products to vulnerable populations, including micronutrient powder and low-dose (20 g/day) lipid-based nutrient supplements (LNS) to young children, micronutrient supplements to pregnant and lactating women, and special foods to specific groups such as fortified meals or snacks for school feeding or treatment of moderately malnourished children. These programs are generally implemented among all eligible individuals in a specific geographic area or setting (e.g., refugee camp, emergency-affected population, school). This has important implications for the design of the evaluation, because there is typically no control group (i.e., no one in the targeted group would receive a placebo, and everyone would be eligible to receive the intervention).
Choice of impact indicators
Micronutrient deficiencies result in various clinical symptoms. Some of these symptoms, such as nightblindness and pellagra, are caused by deficiencies of specific micronutrients, whereas others, such as stunting and increased morbidity, can be caused by several single or combined deficiencies.
When micronutrient supplements are provided to correct a specific deficiency, impact assessments focus on the status of that micronutrient and/or the specific symptom(s) of the deficiency. In the case of high-dose vitamin A capsule distribution as a child survival intervention, for example, population-wide changes in child mortality can be monitored, whereas changes in vitamin A status among specific groups (such as schoolchildren or adult women) can be monitored over time to assess vitamin A fortification of sugar for improvement of vitamin A status.
In the case of interventions with multiple micronutrients (e.g., a micronutrient powder containing 15 vitamins and minerals used for home fortification to reduce the gap between dietary intake and physiological requirements), many biological and functional outcome indicators could potentially be selected. The choice of indicators depends on several factors, including: » Indicators for which data are already available (these data may have been used to guide the decision to implement the intervention); » Specificity of the indicator (i.e., whether the indicator is likely to respond to the intervention, or whether it is also influenced by many other factors); » Responsiveness of the indicator (i.e., whether the indicator is sensitive to change in nutritional status); » Ease and cost of data collection; and » Sample size required to detect a statistically significant change of prevalence or status. Among the most monitored indicators of micronutrient status are hemoglobin concentration; indicators of iron, vitamin A, and iodine status; and indicators of infection and inflammation (e.g., alpha-1 acid glycoprotein and C-reactive protein). Among these indicators, hemoglobin concentration is the easiest to measure in the field and has been the most widely used.
Functional indicators include morbidity (diarrhea, fever, acute respiratory infections), stunting, mortality, night-blindness, and developmental milestones. Most of these indicators are not specific to the deficiency of one particular micronutrient but rather reflect changes in the status of several micronutrients. Most functional indicators and indicators of micronutrient status are also affected by changes in other services or circumstances (including immunization, sanitation, and availability of clean drinking water), which are often addressed concurrently with micronutrient interventions.
Programs distributing multimicronutrient preparations in order to better meet physiologic requirements (i.e., usually providing 1 RNI per dose) usually lead to several anticipated outcomes, including improved health and physical performance. For that reason, and given the criteria listed above, indicators of health and nutritional status that are most commonly included in (regular) health and nutrition surveys and program evaluations are hemoglobin concentration, morbidity, and anthropometry. Additional indicators may include malaria microscopy or rapid diagnostic tests and developmental milestones. Micronutrient interventions are usually included in packages of interventions aimed at improving health and nutritional status, which makes it difficult to determine the impact of specific interventions separately (see discussion of evaluation designs below).
Because hemoglobin concentration is the most widely used indicator, it was discussed in greater detail at the consultation.
Hemoglobin concentration: Considerations
Anemia is widely used as a proxy for iron-deficiency anemia at the population level [1] , because it is easily detected (usually by measuring hemoglobin concentration) and because 40% to 60% of anemia is due to iron deficiency [2] . However, assessment of other indicators of iron status (such as serum ferritin or serum transferrin receptor) and inflammation (to interpret ferritin values) is required to determine what proportion of anemia in a population is due to iron deficiency.
Because virtually all multimicronutrient preparations include iron and other micronutrients (such as vitamins A and C, folic acid, and vitamin B 12 ) that could improve hemoglobin, hemoglobin has been the indicator of choice for assessing the programmatic impact of multimicronutrient interventions. Other biochemical indicators, such as indicators of iron or vitamin A status or infection, were included in only a very few cases, mainly because of cost and the increasing complexity of sample collection, handling, storage, and analysis. However, anemia is also affected by non-nutritional causes, such as parasitic infestation, malaria, HIV/AIDS infection, thalassemia, sickle cell disease, and physiological factors such as age and pregnancy. Some of these factors can be monitored, whereas others are more difficult to detect. Therefore, although the reasons for widespread use of hemoglobin as an indicator of change of micronutrient status are clear, its constraints must be well understood in order to interpret assessment findings appropriately.
Assessment
Hemoglobin concentration can be most easily measured with the HemoCue device, which is portable, uses a rechargeable battery, and requires just one drop of blood (often obtained by fingerprick). Other methods include collection of blood on filter paper (and dissolution in the laboratory) and analysis using Drabkin's solution, which requires a spectrophotometer [3] .
Standardization of methods of blood collection (including fingerprick) and measurement is essential. Because some types of HemoCue cuvettes are hygroscopic, keeping a cuvette container open in humid climates may affect the results. In that case, it is very important to minimize the time during which containers are open and to discard cuvettes within approximately 2 weeks of breaking the seal of any individual container.
Cutoff
The meeting participants agreed that the current hemoglobin cutoffs for anemia (table 1) are appropriate but noted that a cutoff of 100 g/L would be better for children aged 3 to 9 months [4] . Whereas the latter is relevant for individual measurements or when only measuring children in this specific age range, it is most practical to use the cutoff of 110 g/L for the target group of children aged 6 to 59 months. The experts also agreed that the cutoffs indicating mild, moderate, or severe levels of anemia should be maintained and used in reporting of results.
Altitude
Hemoglobin concentration is higher at higher altitudes because of the lower oxygen concentration in the air. Therefore, hemoglobin cutoffs for anemia are higher at higher altitudes (table 2) . A correction for altitude should be made when hemoglobin or anemia levels at different altitudes are compared.
Seasonality
Hemoglobin concentration decreases because of infection, chronic inflammation, or malaria. Therefore, it could respond to seasonal changes, especially related to morbidity patterns. Because of this, it is best when repeated assessments are conducted in the same season, i.e., at 12-month intervals.
Age
Because of rapid expansion of circulating blood volume, iron needs in children are highest before 12 months of age and then gradually decrease, while hemoglobin increases. It is therefore important that interventions specifically target the youngest children and that when following hemoglobin in cohorts of children over time, the natural increase of hemoglobin with age is accounted for when estimating the impact of the intervention.
Physiological status
Pregnant women have the highest iron needs and, as a result, the highest prevalence of anemia among adults in iron-deficient populations. A high prevalence of anemia among nonpregnant women and young children is indicative of an even higher prevalence among pregnant women. After delivery, hemoglobin returns to prepregnancy levels, as long as pregnancy did not induce or worsen iron deficiency. The return to prepregnancy values is aided by lactational amenorrhea, which conserves iron. When anemia prevalence among nonpregnant women is reported, both lactating and nonlactating women can be included (i.e., they do not need to be considered separate groups). Anemia in pregnant women should be reported separately.
Postmenarcheal adolescent girls are also at risk for iron deficiency. After menopause, women's iron needs are comparable to those of adult men, who have the lowest iron needs. Because of their low iron requirement, anemia among adult men is rarely due to iron deficiency, but rather to non-nutritional causes such as thalassemia, parasitic infestation, or other pathology. The meeting participants liked Yip's recommendation to measure anemia prevalence among a sample of adult men to get an indication of whether non-nutritional causes of anemia are prevalent in a population.
Target groups for the intervention and the evaluation
As discussed above, the groups with the highest needs for iron and other micronutrients are usually infants and young children, pregnant women, and women and girls of reproductive age. However, it is important to note that some deficiency diseases, such as pellagra (vitamin B 3 deficiency), preferentially affect adults, including men. Vulnerable groups should be targeted with micronutrient interventions in populations where deficiencies are widely prevalent. In order to specifically increase micronutrient intake among these groups, the most appropriate interventions are those that provide supplements in the form of micronutrient powder or a low-dose micronutrient-rich spread (approximately 20 g/day) for home fortification (most appropriate for young children), capsules or tablets (for older age groups), or special food preparations such as micronutrient-rich snacks or drinks. Although fortification of general foods (such as staples and condiments) and increasing the intake of animal-source foods, fruits, and vegetables to the extent possible will increase the intake of micronutrients, additional sources may be required in order to meet the high micronutrient needs of vulnerable groups. A high anemia prevalence indicates a very likely gap between intake and requirements for iron as well as other micronutrients.
The obvious choice for assessing impact is to collect data among the targeted groups, for example, by following a cohort. However, assessing and interpreting change over time is somewhat tricky among certain groups, in particular among pregnant women and children under 2 years of age.
Pregnant women
Tracking hemoglobin changes among a cohort of pregnant women is challenging, for a number of reasons. First, pregnant women are likely to start interventions at different times during pregnancy, depending on when they first seek antenatal care. An intervention during pregnancy will usually last only 4 to 6 months (depending on timing of the first antenatal visit), and a certain number of supplements needs to be consumed before an impact can be achieved. Physiological changes, such as hemodilution, affect hemoglobin and the serum concentration of micronutrients. Furthermore, finding enough pregnant women in a narrow starting range of gestational age is also very challenging when operating in a programmatic setting. Thus, tracking hemoglobin changes among pregnant women is very difficult, except in carefully controlled circumstances and starting with early detection of pregnancy.
The impact of antenatal supplementation may be best assessed by comparing lactating women who have been exposed to the intervention during pregnancy with women with a child of the same age who were not exposed during their pregnancy. This could be carried out by a cross-sectional comparison (i.e., between a sample from the intervention area and one from a nonintervention area) or a comparison of a sample of lactating women measured before the program started and another sample from the same population measured after the program has been in place for a certain length of time.
Children under 5 years of age
The challenge of measuring hemoglobin among children under 5 years old is ageing, which causes a physiologic increase of hemoglobin that must be accounted for when interpreting hemoglobin change within a cohort. This is especially important when the follow-up period is longer than a couple of months.
Taking the above points into consideration, the meeting participants discussed possible methods for designing program evaluations. The results of their discussions are presented below.
Assessing adherence
In order to be able to interpret the findings of an impact assessment, it is very important to monitor the actual implementation of the program: » Have the eligible individuals received the intervention? » Have they understood why they received the product? » Have they accepted the product? » Have they used the product in the recommended way? (Was the product added to the food of eligible individuals? Was it added to food that was ready for consumption? Did the participants adhere to the recommended dosing frequency?) The findings of the impact assessment can be interpreted only after it has been ascertained that the product was consumed as intended. However, obtaining reliable information on adherence is often difficult. To verify answers obtained from beneficiaries or their caregivers, additional information can be sought by asking to see the supplement container and comparing the actual and expected numbers of remaining sachets. Information can also be collected from beneficiaries' consumption calendars for programs in which such calendars are provided.
Researchers who are collecting and interpreting adherence data must also take into account the supplement delivery schedule and instructions for use. If 30 single doses are provided at 2-month intervals (often referred to as "flexible dosing"), for example, some individuals may finish all doses in the first month, whereas others may have finished them only by the end of the second month (adherence in both cases would be considered good). In this case, adherence assessment would be best conducted at the end of the second month to assess whether all doses had been finished.
Design of the impact evaluation
Various impact evaluation designs can be used to determine whether a particular intervention that has been proven efficacious-or can be assumed to be efficacious based on supplement composition*-indeed has had the desired impact on the target population.
As mentioned above, it is difficult to ascertain impact when an intervention is provided to every eligible person in the target population because of the following factors**: » Lack of a control group of randomly selected individuals, comparable to the individuals receiving the intervention, who would receive a placebo; » The fact that other factors that could affect the outcome measure (such as infections, seasonality, change in age or physiological status, and concurrent implementation of other health and nutritional interventions) cannot be controlled for and that the exposure to such factors thus needs to be monitored and their impact estimated rather than measured because of the lack of a placebo-receiving control group; » Limited control over actual consumption of the micronutrient-rich commodity (distribution can be monitored, but adherence relies on self-reporting). The meeting participants discussed possible evaluation designs for use in situations such as emergency responses, in which it is not feasible to include a randomly selected control group and/or conduct both baseline and follow-up or endline measurements. These designs are presented below. The participants also referred to the concept of distinguishing adequacy, plausibility, and probability designs for evaluating the impact of public health programs, as proposed by Habicht and colleagues [5] .
Cohort tracking or cross-sectional assessments
In many cases, it would be possible to follow a cohort of subjects from before the start of the program or intervention (i.e., baseline) to follow-up or endline * As micronutrient formulation of different micronutrient powders and LNS varies according to situation, it is difficult to obtain efficacy data on all different formulations. However, each product should be formulated using ingredients (or chemical forms of specific nutrients) that have been shown to be efficacious, if not necessarily in the specific selected combinations.
** An exceptional case would be a situation in which a new product was provided in lieu of another product and both products were comparable with regard to nutrient content and formulation but potentially different with regard to acceptability. In this case, one group could continue to receive the already used product while the other group could receive the new product. The impact evaluation would then assess whether the impacts of the two products were equal rather than different, and any difference would be related to acceptance and use of the products rather than to their composition. measurements and to conduct one or more visits to monitor adherence between the baseline and endline. Tracking a cohort is a good option, because assessing change within the same subjects is often more sensitive than assessing change among two groups of subjects measured at different points in time. However, as it is important that data from the cohort represent changes in the rest of the intervention population, it is important to avoid too frequent contact with the cohort that could bias their behavior and/or attitudes toward the intervention. Where possible, data from the cohort must be corroborated with data from cross-sectional surveys among the intervention population in order to verify that the observations among the cohort reflect changes among the larger populations. Those cross-sectional surveys could include indicators of micronutrient status as well as adherence.
Tracking of a cohort is not a good method when an intervention is evaluated over a period of time that is relatively long compared with the period during which individuals are eligible for the intervention. In such a case, it is better to use repeated cross-sectional surveys. For logistics and monitoring considerations, the samples could be selected each time from the same clusters if cluster design is used. As with the tracking of a cohort, it would be important to ensure that these clusters are treated more or less the same as the nonsample clusters to ensure comparability with the rest of the population exposed to the intervention.
In some cases, it may not be possible to conduct a baseline measurement, particularly in the context of emergency programming. Under such circumstances, researchers may consider comparison of cross-sectional data collected from intervention and nonintervention areas, possibly enhanced by inclusion of a nontargeted group (see below).
Comparison group from outside the program area
When evaluating the impact of programs implemented in a certain geographic area, the same target group from nonprogram areas can serve as a comparison group. Such data can be collected purposively (i.e., by the same data collection teams using the same tools and at the same time), or secondary data from sources such as a Demographic and Health Survey can be used. Data from the comparison and intervention groups should preferably be available for the same moment in time.
However, it may be difficult to ascertain a relatively limited impact by comparing data from intervention and comparison groups if members of the comparison group have been excluded from the intervention for a specific reason. Comparison group members often have less need for the intervention, which may mean that they are likely to have a somewhat better nutritional status than members of the intervention group. Likewise, selecting a suitable comparison group is usually not possible in refugee situations, because nearby nonrefugee populations do not receive the same food assistance and hygiene and preventive health services. Another way of choosing a more suitable comparison group is by phasing-in of the intervention.
Step-wedge design or phasing-in of the intervention Some groups within a target population may receive an intervention earlier than others if there are limitations on the capacity of introducing such an intervention to the whole target population. This may include limited supplies, technical expertise, or personnel or other programmatic limitations. Individuals who receive an intervention later can serve as a comparison group for those who received it earlier.
Dose-response relationship among subjects of the intervention group
With any program, there will be a gradient of adherence. Therefore, those who do not adhere to the intervention well can serve as the comparison group for those who do adhere well. In order for such a comparison to have enough statistical power to detect a difference, there should be enough variability in adherence among the measured subjects and adequate numbers of individuals with both low and high adherence to make a valid comparison. In order to collect good adherence data, there should also be regular (e.g., every two months) household visits. However, in order to ensure as much similarity to the intervention population as possible, these visits should not be too frequent.
A nontargeted group as a comparison group
When one target group, for example, children 6 to 59 months of age, receives the intervention, another target group, for example, adolescent girls or schoolage children, could serve as a comparison group. With this comparison, researchers would compare changes in levels of anemia or hemoglobin over time rather than absolute levels of anemia or hemoglobin in the targeted and nontargeted groups. The hypothesis would be that the group who received the intervention would show a different change over time (improvement or no change) compared with the nontargeted group (no change or deterioration).
The "nontargeted" comparison group should be chosen so that the etiology of anemia is not very different between the groups. Thus, for young children, postmenarcheal adolescent girls who have not received iron-rich foods or supplements would be a good comparison group.
Including a nontargeted comparison group can also be considered when only a postintervention comparison is conducted between an intervention and a nonintervention area, for example, in emergencies when baseline measurements have not been conducted. This would be in addition to comparing the intervention area's group of eligible subjects and the nonintervention area's group of subjects within the same target group [6] .
Specific data collection issues
Most data collection issues discussed during the meeting concerned hemoglobin assessment and adherence (see above). The following additional topics were mentioned briefly.
Sampling
Where possible, sampling should be conducted by simple or systematic random sampling rather than cluster sampling.
Ethical clearance
No specific ethical permission is required for crosssectional data collection that is part of routine program monitoring and does not collect identifier information (name and address). However, informed consent (according to Helsinki Declaration standards) must be obtained from all subjects before starting data collection, and ethical permission must be obtained for all nonroutine data collection, including cohort studies and surveys, as well as surveys that collect identifier data.
Consistency and quality of data collection
In order to collect good-quality data and to be able to detect subtle but meaningful changes, it is important that the data collection methods and training of enumerators are standardized, and all data should preferably be collected by the same institution or team over time.
Conclusions
Micronutrient deficiencies, as indicated, for example, by a high anemia prevalence, often trigger implementation of micronutrient interventions, such as introduction of home fortification for young children. Such interventions are often conducted in combination with other public health programs. The choice of preparation should be guided by target group needs, evidence of efficacy of a product or its compounds, acceptability, and cost-effectiveness. In order to determine whether the intervention achieves its intended goal, i.e., a reduction of the prevalence of micronutrient deficiencies and their consequences, the micronutrient intervention and other related interventions must be monitored and evaluated. Monitoring focuses on program implementation and on ascertaining that the intervention is accepted and adhered to by the beneficiaries. Impact evaluation requires a choice of impact indicator(s) and appropriate evaluation design. Hemoglobin concentration is often selected as an impact indicator because it is easy to measure and usually responds to changes in micronutrient status, especially of iron. However, it is not a very specific indicator of iron deficiency or the status of other micronutrients, because it can be influenced by infection and inflammation, parasitic infestation, physiological status (e.g., age and pregnancy), and blood disorders such as thalassemia and sickle cell disease. Thus, the possible impact of a multimicronutrient intervention on hemoglobin varies among populations, and an impact (or lack thereof) on hemoglobin concentration does not provide ultimate proof of impact or absence of impact of the micronutrient intervention. Inclusion of additional indicators, such as those of growth and morbidity, as well as measuring the status of other micronutrients, can provide further insights. For special situations (such as emergencies and refugee settings) in which all eligible subjects receive the intervention and a suitable comparison group or area may not be available, alternative evaluation designs can be considered. These include assessment of a cohort over time, repeated cross-sectional surveys, inclusion of a nontargeted group to compare change between targeted and nontargeted groups, or comparison with a nonintervention group, for example, one that is exposed to the intervention at a later stage (step-wedge design) or is a subgroup with poor adherence to the intervention.
